Metabolon is thrilled to be presenting at the upcoming 5th Research Conference for Toxicity Mechanisms of Pharmaceuticals. The conference is being held in Tokyo, Japan, and consists of four symposiums that will give new knowledge to non-clinical safety researchers: Signal Transduction of Cell Death, Determining if Co-Culture of Immune Cells is Necessary for MPS, Understanding AOP, and Off-Target Toxicity Target Search. Metabolon’s Business Development Executive, Shoji Kaminaka, will be presenting, “Metabolomic Applications in Pharmacotoxicology.”
Search
Recent Posts
- Metabolon Collaborates with The Michael J. Fox Foundation to Advance Multiomic Analyses for Parkinson’s Research
- Metabolon’s Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity
- ADPD 2026
- Metabolon Names Andrew Messick Chief Financial Officer
- Metabolon Appoints Celia Reyes as Vice President of Human Resources


Recent Comments